5-HT(2A) receptor or α1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex

European Journal of Pharmacology

Volumn 367, Issue 2-3, 1999, Pages 197-206

  Marek, Gerard J ^a   Aghajanian, George K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); Dopamine; Glutamate; Neocortex; Norepinephrine

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; DOPAMINE; GLUTAMIC ACID; NORADRENALIN; SEROTONIN 2A RECEPTOR; AMPA RECEPTOR; BIOGENIC AMINE; MU OPIATE RECEPTOR; PRAZOSIN; SEROTONIN; SEROTONIN RECEPTOR; SODIUM CHANNEL BLOCKING AGENT; YOHIMBINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; INTRACELLULAR RECORDING; MALE; NEOCORTEX; NEUROTRANSMITTER RELEASE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; ANIMAL; CLASSIFICATION; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BIOGENIC MONOAMINES; DOPAMINE; EXCITATORY POSTSYNAPTIC POTENTIALS; MALE; NOREPINEPHRINE; PRAZOSIN; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, AMPA; RECEPTORS, OPIOID, MU; RECEPTORS, SEROTONIN; SEROTONIN; SODIUM CHANNEL BLOCKERS; YOHIMBINE;

EID: 0032587892     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00945-5     Document Type: Article

References (57)

1. Aghajanian G.K., Wang R.Y. Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res. 122:1977;229-242.
2. Aghajanian G.K., Rasmussen K. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse. 3:1989;331-338.
3. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
4. Altar C.A., Wasley A.M., Neale R.F., Stone G.A. Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain. Brain Res. Bull. 16:1986;517-525.
5. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 40:1991;399-412.
6. Arnsten A.F., Goldman-Rakic P.S. Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res. 306:1984;9-18.
7. Arnsten A.F.T., Jentsch J.D. The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys. Pharmacol. Biochem. Behav. 58:1997;55-59.
8. 2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Synapse. 17:1994;173-181.
9. 2 receptors and serotonergic axons in rat neocortex. Brain Res. 453:1988;315-328.
10. Branchereau P., Van Bockstaele E.J., Chan J., Pickel V.M. Pyramidal neurons in rat prefrontal cortex show a complex synaptic response to single electrical stimulation of the locus coeruleus region: evidence for antidromic activation and GABAergic inhibition using in vivo intracellular recording and electron microscopy. Synapse. 22:1996;313-331.
11. Breier A., Elman I., Goldstein D.S. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action. Adv. Pharmacol. 42:1998;785-788.
12. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology. 15:1996;442-455.
13. Cedarbaum J.M., Aghajanian G.K. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 178:1978;1-16.
14. Cohen B.M., Lipinski J.F. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life Sci. 39:1986;2571-2580.
15. Connors B.W., Gutnick M.J. Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci. 13:1990;99-104.
16. DeFelipe J., Farinas I. The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog. Neurobiol. 39:1992;563-607.
17. Delphs J.M., Kong H., Mestek A., Chen Y., Yu L., Reisine T., Chesselet M.-F. Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J. Comp. Neurol. 345:1994;46-68.
18. 1A adrenergic receptor mRNA in the rat brain visualized by in situ hybridization. J. Comp. Neurol. 386:1997;358-378.
19. Duxon M.S., Flanigan T.P., Reavley A.C., Baxter G.S., Blackburn T.P., Fone K.C.F. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience. 76:1996;323-329.
20. + currents in cat neocortical neurons. J. Neurophysiol. 61:1989;245-256.
21. 1-Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci. 15:1994;167-170.
22. 2 receptor-mediated excitation of interneurons in pirform cortex: antagonism by atypical antipsychotic drugs. Neuroscience. 58:1994;515-525.
23. Gurevich E.V., Joyce J.N. Alteration in the cortical serotonergic system in schizophrenia: a postmortem study. Biol. Psychiatry. 42:1997;529-545.
24. 2-adrenergic receptors. Mol. Pharmacol. 40:1991;407-412.
25. Hornung R., Presek P., Glossmann H. Alpha adrenoceptors in rat brain: direct identification with prazosin. Naunyn-Schmiedeberg's Arch. Pharmacol. 308:1979;223-230.
26. Jakab R.L., Goldman-Rakic P.S. 5-HT2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogens in pyramidal cell apical dendrites. Proc. Natl. Acad. Sci. U.S.A. 95:1998;735-740.
27. Jarvik M.E., Chorover S. Impairment by lysergic acid diethylamide of accuracy in performance of a delayed alternation test in monkeys. Psychopharmacologia. 1:1960;221-230.
28. Kennett G.A., Wood M.D., Bright F., Cilia J., Piper D.C., Gager T., Thomas D., Baxter G.S., Forbes I.T., Ham P., Blackburn T.P. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic properties. Br. J. Pharmacol. 117:1996;427-434.
29. Kennett G.A., Wood M.D., Bright F., Trail B., Riley G., Holland V., Avenell K.Y., Stean T., Upton N., Bromidge S., Forbes I.T., Brown A.M., Middlemiss D.N., Blackburn T.P. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology. 36:1997;609-620.
30. Luppi P.-H., Aston-Jones G., Akaoka H., Chouvet G., Jouvet M. Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and phaseolus vulgaris leucoagglutinin. Neuroscience. 65:1995;119-160.
31. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350:1994;412-438.
32. Mansour A., Fox C.A., Thompson R.A., Akil H., Watson S.J. μ-Opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding. Brain Res. 643:1994;245-265.
33. 2A receptor antagonist. Eur. J. Pharmacol. 259:1994;137-141.
34. 1B-Adrenoceptor-mediated excitation of piriform cortical interneurons. Eur. J. Pharmacol. 305:1996;95-100.
35. Marek G.J., Aghajanian G.K. 5-HT-induced EPSCs in neocortical layer V pyramidal cells: suppression by μ-opiate receptor activation. Neuroscience. 86:1998;485-497.
36. McCormick D.A., Connors B.W., Lighthall J.W., Prince D.A. Comparative electrophysiology of pyramidal and sparsely spiny neurons of the neocortex. J. Neurophysiol. 54:1985;782-806.
37. McCune S.K., Voigt M.M., Hill J.M. Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience. 57:1993;143-151.
38. i values. J. Pharmacol. Exp. Ther. 251:1989;238-246.
39. 1'-adrenoceptors in rat brain Naunyn-Schmiedeberg's Arch. Pharmacol. 312:1980;23-26.
40. 1-Adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents and primates. Brain Res. 419:1987;65-75.
41. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, Academic Press, Orlando, FL.
42. 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J. Neurosci. 14:1994;4252-4268.
43. Pineda J., Kogan J.H., Aghajanian G.K. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J. Neurosci. 16:1996;1389-1399.
44. 2C receptors. Mol. Brain Res. 23:1994;163-178.
45. 2 binding affinity. Neuropsychopharmacology. 1:1988;101-107.
46. Rasmussen K., Kendrick W.T., Kogan J.H., Aghajanian G.K. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology. 15:1996;497-505.
47. Read H.L., Beck S.G., Dun N.J. Serotonergic suppression of interhemispheric cortical synaptic potentials. Brain Res. 643:1994;17-28.
48. Schoepp D.D., Lodge D., Bleakman D., Leander J.D., Tizzano J.P., Wright R.A., Palmer A.J., Salhoff C.R., Ornstein P.L. In vitro and in vivo antagonism of AMPA receptor activation by (3S,4aR,6R,8aR)-6-[2-(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylic acid. Neuropharmacology. 34:1995;1159-1168.
49. Schreiber R., Brocco M., Audinot V., Gobert A., Veiga S., Millan M.J. (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J. Pharmacol. Exp. Ther. 273:1995;101-112.
50. 2-activated interneuron. Brain Res. 506:1990;62-69.
51. Tanaka E., North R.A. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J. Neurophysiol. 69:1993;1749-1757.
52. Tanaka E., North R.A. Opioid actions on rat anterior cingulate cortex neurons in vitro. J. Neurosci. 14:1994;1106-1113.
53. Tempel A., Zukin R.S. Neuroanatomical patterns of the μ, δ, and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. U.S.A. 84:1987;4308-4312.
54. 2B receptor: evidence for species differences. J. Pharmacol. Exp. Ther. 276:1996;720-727.
55. Williams J., Spurlock G., McGuffin P., Mallet J., Nothen M.M., Gill M., Aschauer H., Nylander P.-O., Macciardi F., Owen M.J. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet. 347:1996;1294-1296.
56. 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.
57. Yang C.R., Seamans J.K. Dopamine D1 receptor actions in layer V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J. Neurosci. 16:1996;1922-1935.